Upamostat is a synthetic piperazine derivative functioning as an inhibitor of neutrophil elastase and other serine proteases, researched primarily for its potential application in managing chronic inflammatory… Read more







Upamostat is a synthetic piperazine derivative functioning as an inhibitor of neutrophil elastase and other serine proteases, researched primarily for its potential application in managing chronic inflammatory conditions such as cystic fibrosis. This category comprises the active pharmaceutical ingredient alongside its related compounds, including synthetic impurities and stable isotope labelled analogues, which are essential for comprehensive analytical workflows. Pharmaceutical laboratories utilize these reference standards for critical tasks such as impurity profiling, structural elucidation, and method validation to ensure regulatory compliance during drug development. Stable isotope labelled compounds, such as deuterium-labelled variants, serve as internal standards for precise quantification in mass spectrometry and pharmacokinetic studies. By providing access to these characterized substances, analysts can perform accurate quality control assessments and stability testing, facilitating the rigorous evaluation of Upamostat formulations throughout the drug lifecycle.